HemaCare’s Global Head of Cell Therapy speaking at 1:30 pm EST on January 23, 2019
(Los Angeles, CA – January 15, 2019) HemaCare Corporation (OTCMKTS: HEMA), a global leader and trusted brand in the customization of human-derived biological products and services for biomedical research, drug discovery, and cellular therapy process development, announced today that Dominic Clarke, Ph.D., Global Head of Cell Therapy, will chair and present at Phacilitate Leaders World, one of the largest Cell and Gene Therapy conferences globally. [Read more…]